Philip H Keiser

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. pmc Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment
    Philip H Keiser
    University of Texas Southwestern Medical Center, Dallas, Texas, USA
    BMC Infect Dis 5:2. 2005
  2. doi request reprint Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational database study
    Philip H Keiser
    Department of Internal Medicine, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX 75390 9113, USA
    Int J STD AIDS 19:561-2. 2008
  3. ncbi request reprint The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis
    Richard H Haubrich
    University of California at San Diego, San Diego, California, USA
    AIDS 16:F33-40. 2002
  4. ncbi request reprint A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575
    Richard H Haubrich
    University of California, San Diego, California, USA
    AIDS 19:295-302. 2005

Detail Information

Publications4

  1. pmc Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment
    Philip H Keiser
    University of Texas Southwestern Medical Center, Dallas, Texas, USA
    BMC Infect Dis 5:2. 2005
    ..Hyperlipidemia secondary to protease inhibitors (PI) may abate by switching to anti-HIV medications without lipid effects...
  2. doi request reprint Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational database study
    Philip H Keiser
    Department of Internal Medicine, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX 75390 9113, USA
    Int J STD AIDS 19:561-2. 2008
    ....
  3. ncbi request reprint The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis
    Richard H Haubrich
    University of California at San Diego, San Diego, California, USA
    AIDS 16:F33-40. 2002
    ..To evaluate the clinical significance of hypersusceptibility to non-nucleoside reverse transcriptase inhibitors (NNRTI)...
  4. ncbi request reprint A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575
    Richard H Haubrich
    University of California, San Diego, California, USA
    AIDS 19:295-302. 2005
    ..To assess phenotype susceptibility testing (PHENO) with standard of care (SOC) to improve antiretroviral therapy...